{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:17:27Z","timestamp":1768868247621,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.tvjl.2024.106210","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:30:22Z","timestamp":1722886222000},"page":"106210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring montelukast in dogs: A preliminary pharmacokinetic study following oral administration under fasted and fed conditions"],"prefix":"10.1016","volume":"307","author":[{"given":"Charbel","family":"Fadel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"\u0141ebkowska-Wieruszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Serih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amnart","family":"Poapolathep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tvjl.2024.106210_bib1","first-page":"115","article-title":"Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast","volume":"14","author":"Angelova-Fischer","year":"2005","journal-title":"Acta Dermatovenerologica Alpina, Pannonica, et Adriatica"},{"key":"10.1016\/j.tvjl.2024.106210_bib2","unstructured":"Anonymous. (2012). FDA, Food and Drug Adminsitration. Highlights of Prescribing Information: Singulair (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules. Initial U.S. Approval: 1998. [Revised by FDA]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021409s036lbl.pdf Accessed 28 May 2024."},{"key":"10.1016\/j.tvjl.2024.106210_bib3","series-title":"The Physiological Basis of Veterinary Clinical Pharmacology","author":"Baggot","year":"2001"},{"key":"10.1016\/j.tvjl.2024.106210_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smim.2017.08.007","article-title":"Recent advances in clinical development of leukotriene B4 pathway drugs","volume":"33","author":"Bhatt","year":"2017","journal-title":"Seminars in Immunology"},{"issue":"4","key":"10.1016\/j.tvjl.2024.106210_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/med.20071","article-title":"Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends","volume":"27","author":"Capra","year":"2007","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.tvjl.2024.106210_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/9780470959916.ch14","article-title":"Study design and data analysis","author":"Chittenden","year":"2011","journal-title":"Comparative Pharmacokinetics: Principles, Techniques, and Applications"},{"issue":"4","key":"10.1016\/j.tvjl.2024.106210_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.0959-4493.2001.00254.x","article-title":"Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis","volume":"12","author":"Crow","year":"2001","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2024.106210_bib8","unstructured":"EMA; European Medicines Agency. (2012). Guideline on bioanalytical method validation. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf Last accessed on 5 June 2024."},{"key":"10.1016\/j.tvjl.2024.106210_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jvp.13444","article-title":"Comparative disposition kinetics of oral deracoxib in sheep and goats","author":"Fadel","year":"2024","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.tvjl.2024.106210_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/jvp.13396","article-title":"Pharmacokinetics of robenacoxib following single intravenous, subcutaneous and oral administrations in Baladi goats (Capra hircus)","volume":"46","author":"Fadel","year":"2023","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.tvjl.2024.106210_bib11","first-page":"454","article-title":"Medications for chronic asthma","volume":"94","author":"Falk","year":"2016","journal-title":"American Family Physician"},{"key":"10.1016\/j.tvjl.2024.106210_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-62703-050-2_16","article-title":"Non-compartmental analysis","volume":"929","author":"Gabrielsson","year":"2012","journal-title":"Methods in Molecular Biology"},{"issue":"4","key":"10.1016\/j.tvjl.2024.106210_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-199120040-00001","article-title":"Noncompartmental versus compartmental modelling in clinical pharmacokinetics","volume":"20","author":"Gillespie","year":"1991","journal-title":"Clinical Pharmacokinetics"},{"issue":"9","key":"10.1016\/j.tvjl.2024.106210_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00228-012-1239-0","article-title":"Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers","volume":"68","author":"Hegazy","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1016\/j.tvjl.2024.106210_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/jvp.12995","article-title":"Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration","volume":"44","author":"Homedes","year":"2021","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"14","key":"10.1016\/j.tvjl.2024.106210_bib16","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/ijms20143580","article-title":"The role of leukotrienes as potential therapeutic targets in allergic disorders","volume":"20","author":"Jo-Watanabe","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.tvjl.2024.106210_bib17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.3.e48","article-title":"Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years","volume":"108","author":"Knorr","year":"2001","journal-title":"Pediatrics"},{"issue":"26","key":"10.1016\/j.tvjl.2024.106210_bib18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/vr.152.26.804","article-title":"Efficacy of montelukast in the treatment of chronic obstructive pulmonary disease in five horses","volume":"152","author":"Kolm","year":"2003","journal-title":"The Veterinary Record"},{"issue":"4","key":"10.1016\/j.tvjl.2024.106210_bib19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jaci.2018.02.024","article-title":"Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor","volume":"142","author":"Lazarinis","year":"2018","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.tvjl.2024.106210_bib20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.clinthera.2015.03.027","article-title":"Asthma treatments and mental health visits after a food and drug administration label change for leukotriene inhibitors","volume":"37","author":"Lu","year":"2015","journal-title":"Clinical Therapeutics"},{"issue":"1-2","key":"10.1016\/j.tvjl.2024.106210_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcp.2005.10.003","article-title":"CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors","volume":"71","author":"Mamedova","year":"2005","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tvjl.2024.106210_bib22","unstructured":"Martin-Jimenez, T. (2010). Update of therapies for feline asthma. In: Proceedings of the 82nd Annual Western Veterinary Conference Notes (WVC 2010). Las Vegas, NV, USA. Available at: https:\/\/www.vin.com\/doc\/?id=4439148. Accessed April 29, 2024."},{"key":"10.1016\/j.tvjl.2024.106210_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12917-015-0514-6","article-title":"Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)","volume":"11","author":"Olivry","year":"2015","journal-title":"BMC Veterinary Research"},{"issue":"3","key":"10.1016\/j.tvjl.2024.106210_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-3164.2003.00335.x","article-title":"Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis","volume":"14","author":"Olivry","year":"2003","journal-title":"Veterinary Dermatology"},{"issue":"4","key":"10.1016\/j.tvjl.2024.106210_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jyp.2013.10.006","article-title":"Development and validation of RP-HPLC method with ultraviolet detection for estimation of montelukast in rabbit plasma: application to preclinical pharmacokinetics","volume":"5","author":"Ranjan","year":"2013","journal-title":"Journal of Young Pharmacists: Journal of Young Pharmacists"},{"issue":"1","key":"10.1016\/j.tvjl.2024.106210_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1465-9921-7-42","article-title":"CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1\/2 phosphorylation","volume":"7","author":"Ravasi","year":"2006","journal-title":"Respiratory Research"},{"issue":"6","key":"10.1016\/j.tvjl.2024.106210_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1098-612X-06-00162-8","article-title":"Snots & snuffles: chronic feline upper respiratory syndromes","volume":"8","author":"Scherk","year":"2006","journal-title":"Journal of Feline Medicine and Surgery"},{"issue":"9","key":"10.1016\/j.tvjl.2024.106210_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3109\/02770903.2013.823447","article-title":"A review on leukotrienes and their receptors with reference to asthma","volume":"50","author":"Singh","year":"2013","journal-title":"The Journal of Asthma"},{"key":"10.1016\/j.tvjl.2024.106210_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-10324-7_2","article-title":"Species differences in pharmacokinetics and pharmacodynamics","volume":"199","author":"Toutain","year":"2010","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"3","key":"10.1016\/j.tvjl.2024.106210_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/030098589002700305","article-title":"Morphometric analyses of the skin of dogs with atopic dermatitis and correlations with cutaneous and plasma histamine and total serum IgE","volume":"27","author":"Wilkie","year":"1990","journal-title":"Veterinary Pathology"},{"issue":"9","key":"10.1016\/j.tvjl.2024.106210_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/(SICI)1099-081X(199712)18:9<769::AID-BDD60>3.0.CO;2-K","article-title":"Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers","volume":"18","author":"Zhao","year":"1997","journal-title":"Biopharmaceutics Drug Disposition"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023324001497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023324001497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T04:40:43Z","timestamp":1725511243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023324001497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"alternative-id":["S1090023324001497"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2024.106210","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring montelukast in dogs: A preliminary pharmacokinetic study following oral administration under fasted and fed conditions","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2024.106210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106210"}}